Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Henderson opened renovated salons in Moscow and Cheboksary

11/15/24 HNFG

TCS Holding shareholders approved the change of name to T-Technologies

11/14/24 T

Shareholders of T-Bank approved dividends

11/14/24 T

Mechel reduced pig iron and steel output by 5%

11/14/24 MTLR

Bank of Russia closes access to any foreign securities other than EAEU to non-qualified persons

11/14/24 MOEX

CarMoney's lending volume grew by 2% at the end of 9 months

11/14/24 CARM

Board of Directors of Tatneft recommended dividends

11/14/24 TATN

Finuservices has conducted a pilot issue of DFA

11/14/24 MOEX

Tattelecom reported for 9 months of 2024 by RAS

11/14/24 TTLK

CarMoney reported for 9 months of 2024 by IFRS

11/14/24 CARM